Interleukin 2 Topical Cream for Treatment of Diabetic Foot Ulcer:

NewsBot · Aug 16, 2015

Members do not see these Ads. Sign Up.
Interleukin 2 Topical Cream for Treatment of Diabetic Foot Ulcer: Experiment Protocol.
Chan SW
JMIR Res Protoc. 2015 Aug 14;4(3):e89. doi: 10.2196/resprot.4036

BACKGROUND:
It is estimated there are 2.9 million diabetic patients in the United Kingdom, and around 5%-7% of patients have diabetic ulcers. This number will continue to increase globally. Diabetic ulcers are a major economic burden on the healthcare system. More than ?650 million is spent on foot ulcers or amputations each year, and up to 100 people a week have a limb amputated due to diabetes. In T1DM, the level of IL-2 is reduced, and hence, wound healing is in a prolonged inflammatory phase. It is not known if IL-2 topical cream can shorten the healing process in T1DM patients.
OBJECTIVE:
The objective of this study is to understand the pathophysiology in type 1 diabetes (T1DM) and investigate possible future treatment based on its clinical features. The hypothesis is that IL-2 cream can speed up wound healing in NOD mice and that this can be demonstrated in a ten-week study. An experiment protocol is designed in a mouse model for others to conduct the experiment. The discussion is purely based on diabetic conditions; lifestyle influences like smoking and drinking are not considered.
METHODS:
Skin incisions will be created on 20 nonobese diabetic (NOD) mice, and IL-2 topical cream will be applied in a 10-week study to prove the hypothesis. Mice will be randomly and equally divide into two groups with one being the control group.
RESULTS:
T1DM patients have a decreased number of T regulatory (Treg) cells and interleukin 2 (IL-2). These are the keys to the disease progression and delay in wound healing. Diabetic ulcer is a chronic wound and characterized by a prolonged inflammatory phase.
CONCLUSIONS:
If the experiment is successful, T1DM patients will have an alternative, noninvasive treatment of foot ulcers. In theory, patients with other autoimmune diseases could also use IL-2 topical cream for treatment.
Click to expand...

Admin2 · Aug 16, 2015

Related Topics:
Haemoglobin spray (Granulox) for diabetic foot ulcers
Doxium for diabetic foot infections
Skin replacement therapies for diabetic foot ulcers
Selinexor for diabetic foot ulcers
Aurix for diabetic foot ulcers
BioChaperone PDGF spray for diabetic foot ulcers
LeucoPatch™ for Diabetic Foot Ulcers
Pirfenidone for Diabetic Ulcers
KLOX BioPhotonic System for Diabetic Foot Ulcers
Brilacidin for diabetic foot wounds
EpiFix for diabetic foot ulcers
Lipo-PGE for diabetic foot ulcers
CollaRx for Diabetic Foot Ulcers
DermaPure for diabetic foot ulcers
MatriStem for diabetic foot ulcers
Resveratrol for diabetic foot ulcers
Santyl (colleganase) for diabetic foot ulcers
Granexin for diabetic foot ulcer
Olive Oil for diabetic foot ulcers
Nexodyn™ for diabetic foot ulcers
NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers
Biovance for Diabetic Foot Ulcers

NewsBot The Admin that posts the news.

Admin2 Administrator Staff Member

Serum Concentration of Interleukin-18 in Diabetic Patients with Foot Ulcers

Topical Medications for Treating Diabetic Foot Ulcers - A Systematic Review

Topical Esmolol Hydrochloride for Diabetic Foot Ulcers

Topical oxygen therapy in acute traumatic musculoskeletal wounds of the foot and ankle

ENERGI-F703 gel, as a new topical treatment for diabetic foot and leg ulcers:

Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy

Topical tx for wound colonized with Pseudomonas.

Share This Page